Cargando…
Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice
Cervical cancer (CC) is usually initiated by infection with high‐risk types of human papillomavirus (HPV). The HPV E6 and E7 proteins target p53 and RB, respectively, but other cellular targets likely exist. We generated uterus‐specific MOB1A/B double KO (uMob1DKO) mice, which immediately developed...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541006/ https://www.ncbi.nlm.nih.gov/pubmed/32716083 http://dx.doi.org/10.1111/cas.14581 |
_version_ | 1783591317022965760 |
---|---|
author | Nishio, Miki To, Yoko Maehama, Tomohiko Aono, Yukari Otani, Junji Hikasa, Hiroki Kitagawa, Akihiro Mimori, Koshi Sasaki, Takehiko Nishina, Hiroshi Toyokuni, Shinya Lydon, John P. Nakao, Kazuwa Wah Mak, Tak Kiyono, Tohru Katabuchi, Hidetaka Tashiro, Hironori Suzuki, Akira |
author_facet | Nishio, Miki To, Yoko Maehama, Tomohiko Aono, Yukari Otani, Junji Hikasa, Hiroki Kitagawa, Akihiro Mimori, Koshi Sasaki, Takehiko Nishina, Hiroshi Toyokuni, Shinya Lydon, John P. Nakao, Kazuwa Wah Mak, Tak Kiyono, Tohru Katabuchi, Hidetaka Tashiro, Hironori Suzuki, Akira |
author_sort | Nishio, Miki |
collection | PubMed |
description | Cervical cancer (CC) is usually initiated by infection with high‐risk types of human papillomavirus (HPV). The HPV E6 and E7 proteins target p53 and RB, respectively, but other cellular targets likely exist. We generated uterus‐specific MOB1A/B double KO (uMob1DKO) mice, which immediately developed cervical squamous cell carcinoma in situ. Mutant cervical epithelial cells showed YAP1‐dependent hyperproliferation, altered self‐renewal, impaired contact inhibition, and chromosomal instability. p53 activation was increased in uMob1DKO cells, and additional p53 loss in uMob1DKO mice accelerated tumor invasion. In human CC, strong YAP1 activation was observed from the precancerous stage. Human cells overexpressing HPV16 E6/E7 showed inactivation of not only p53 and RB but also PTPN14, boosting YAP1 activation. Estrogen, cigarette smoke condensate, and PI3K hyperactivation all increased YAP1 activity in human cervical epithelial cells, and PTPN14 depletion along with PI3K activation or estrogen treatment further enhanced YAP1. Thus, immediate CC onset may initiate when YAP1 activity exceeds an oncogenic threshold, making Hippo‐YAP1 signaling a major CC driver. |
format | Online Article Text |
id | pubmed-7541006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75410062020-10-09 Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice Nishio, Miki To, Yoko Maehama, Tomohiko Aono, Yukari Otani, Junji Hikasa, Hiroki Kitagawa, Akihiro Mimori, Koshi Sasaki, Takehiko Nishina, Hiroshi Toyokuni, Shinya Lydon, John P. Nakao, Kazuwa Wah Mak, Tak Kiyono, Tohru Katabuchi, Hidetaka Tashiro, Hironori Suzuki, Akira Cancer Sci Carcinogenesis Cervical cancer (CC) is usually initiated by infection with high‐risk types of human papillomavirus (HPV). The HPV E6 and E7 proteins target p53 and RB, respectively, but other cellular targets likely exist. We generated uterus‐specific MOB1A/B double KO (uMob1DKO) mice, which immediately developed cervical squamous cell carcinoma in situ. Mutant cervical epithelial cells showed YAP1‐dependent hyperproliferation, altered self‐renewal, impaired contact inhibition, and chromosomal instability. p53 activation was increased in uMob1DKO cells, and additional p53 loss in uMob1DKO mice accelerated tumor invasion. In human CC, strong YAP1 activation was observed from the precancerous stage. Human cells overexpressing HPV16 E6/E7 showed inactivation of not only p53 and RB but also PTPN14, boosting YAP1 activation. Estrogen, cigarette smoke condensate, and PI3K hyperactivation all increased YAP1 activity in human cervical epithelial cells, and PTPN14 depletion along with PI3K activation or estrogen treatment further enhanced YAP1. Thus, immediate CC onset may initiate when YAP1 activity exceeds an oncogenic threshold, making Hippo‐YAP1 signaling a major CC driver. John Wiley and Sons Inc. 2020-08-21 2020-10 /pmc/articles/PMC7541006/ /pubmed/32716083 http://dx.doi.org/10.1111/cas.14581 Text en © 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Carcinogenesis Nishio, Miki To, Yoko Maehama, Tomohiko Aono, Yukari Otani, Junji Hikasa, Hiroki Kitagawa, Akihiro Mimori, Koshi Sasaki, Takehiko Nishina, Hiroshi Toyokuni, Shinya Lydon, John P. Nakao, Kazuwa Wah Mak, Tak Kiyono, Tohru Katabuchi, Hidetaka Tashiro, Hironori Suzuki, Akira Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice |
title | Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice |
title_full | Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice |
title_fullStr | Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice |
title_full_unstemmed | Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice |
title_short | Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice |
title_sort | endogenous yap1 activation drives immediate onset of cervical carcinoma in situ in mice |
topic | Carcinogenesis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541006/ https://www.ncbi.nlm.nih.gov/pubmed/32716083 http://dx.doi.org/10.1111/cas.14581 |
work_keys_str_mv | AT nishiomiki endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT toyoko endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT maehamatomohiko endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT aonoyukari endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT otanijunji endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT hikasahiroki endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT kitagawaakihiro endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT mimorikoshi endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT sasakitakehiko endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT nishinahiroshi endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT toyokunishinya endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT lydonjohnp endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT nakaokazuwa endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT wahmaktak endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT kiyonotohru endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT katabuchihidetaka endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT tashirohironori endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice AT suzukiakira endogenousyap1activationdrivesimmediateonsetofcervicalcarcinomainsituinmice |